Cigna Group: Unlocking hidden upside in a Health Services Powerhouse (paid version)
Our intrinsic valuation of The Cigna Group on July 15th, 2026
The Cigna Group is a giant in health services, now shifting its weight from volatile insurance lines toward scalable, data‑driven solutions and specialty pharmacy. This strategic pivot, paired with leadership change and a share price near its recent highs, makes today a particularly interesting moment for investors to judge whether the market truly reflects the company’s future earning power.
Short profile
The Cigna Group is a global health company built around two main divisions: Cigna Healthcare, which provides medical, behavioral, dental and related coverage, and Evernorth Health Services, which offers pharmacy benefit management, specialty pharmacy and data‑driven care solutions.
Over the last four quarters the group generated annual sales of about USD 277,892 million and an operating result of USD 11,626 million, corresponding to an operating margin of roughly 4.2%, underlining the scale of its integrated health services platform.
The company is currently reshaping its portfolio toward capital‑light, service‑oriented businesses, stepping back from more volatile segments while leaning into technology, analytics and AI to keep care affordable and more personalized, in line with broader industry trends toward value‑based care, digital health, and tighter cost control in U.S. managed care.
Current developments
Cigna is in the midst of a leadership transition, with long‑time CEO David Cordani handing the reins to Brian Evanko, signaling continuity in disciplined capital allocation but a stronger emphasis on data‑driven, AI‑enabled health services and personalization. Strategically, the group is exiting more politically exposed and volatile insurance lines while doubling down on Evernorth, specialty pharmacy and employer‑sponsored health plans, all supported by a new rebate‑free pharmacy benefits model designed to fit evolving regulation and client demand for transparency.
At the industry level, U.S. health insurers face rising medical inflation, regulatory pressure on drug pricing and prior authorization, and growing expectations for digital access and integrated care, making Cigna’s focus on scalable health services, data ecosystems and partnership‑driven solutions a central driver of its future positioning.
Our share value calculation on July 15, 2026 for paid subscribers:
